Pierre Gravier - 12 Dec 2023 Form 4 Insider Report for PTC THERAPEUTICS, INC. (PTCT)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Avraham S. Adler, Attorney-in-Fact
Issuer symbol
PTCT
Transactions as of
12 Dec 2023
Net transactions value
+$198,736
Form type
4
Filing time
14 Dec 2023, 16:38:32 UTC
Previous filing
07 Dec 2023
Next filing
16 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PTCT Common Stock Purchase $198,736 +7,700 +30% $25.81 33,700 12 Dec 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This price represents the weighted average price of purchase transactions that were executed in multiple trades at prices ranging from $25.77 to $25.82 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.